v1
Phase II studies of the glycine antagonist GV150526 in acute stroke : the North American experience. The North American Glycine Antagonist in Neuroprotection (GAIN) Investigators.
Identifier:nobleid.org/w1/20260515/F0014DBB
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/F0014DBB)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims
Paper Authors